“To test the effectiveness and long term safety of cannabinoids in multiple sclerosis (MS), in a follow up to the main Cannabinoids in Multiple Sclerosis (CAMS) study.
There was suggestive evidence for treatment effects of Δ9-THC on some aspects of disability.
There were no major safety concerns.
Overall, patients felt that these drugs were helpful in treating their disease.
These data provide limited evidence for a longer term treatment effect of cannabinoids.”